Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab-Reference-Cited by-同舟云学术

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

Published:2020-03-01 Issue:3 Volume:6 Page:402
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kelly Ciara M.¹²³,Antonescu Cristina R.⁴,Bowler Timothy⁴,Munhoz Rodrigo⁴,Chi Ping²⁴,Dickson Mark A.¹²,Gounder Mrinal M.¹²,Keohan Mary Louise¹²,Movva Sujana¹,Dholakia Reena¹,Ahmad Hamza¹,Biniakewitz Matthew¹,Condy Mercedes¹,Phelan Haley¹,Callahan Margaret¹²⁵,Wong Phillip¹⁵⁶,Singer Sam²⁴,Ariyan Charlotte²⁴,Bartlett Edmund K.²⁴,Crago Aimee²⁴,Yoon Sam²⁴,Hwang Sinchun⁴,Erinjeri Joseph P.⁴,Qin Li-Xuan⁴,Tap William D.¹²,D’Angelo Sandra P.¹²⁵

Affiliation:

1. Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York

2. Weill Cornell Medical College, New York, New York

3. Department of Sarcoma Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

4. Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York

5. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York

6. Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2758838/jamaoncology_kelly_2020_oi_190107.pdf

Reference33 articles.

1. Sarcoma immunotherapy: past approaches and future directions.;D’Angelo;Sarcoma,2014

2. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas.;Cancer Genome Atlas Research Network;Cell,2017

3. Cancer statistics, 2016.;Siegel;CA Cancer J Clin,2016

4. Management of soft-tissue sarcomas: an overview and update.;Singer;Lancet Oncol,2000

5. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.;Seddon;Lancet Oncol,2017

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors;Radiotherapy and Oncology;2024-11

2. Multifaceted metabolic role of infections in the tumor microenvironment;Current Opinion in Biotechnology;2024-10

3. Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy;Genes;2024-09-11

4. New strategies in soft tissue sarcoma treatment;Journal of Hematology & Oncology;2024-09-02

5. Translation of oncolytic viruses in sarcoma;Molecular Therapy: Oncology;2024-09